Quality-adjusted survival (Q-TWiST) anal
โ
Rosendahl, Ingvar; Kiebert, Gwendoline M.; Curran, Desmond; Cole, Bernhard F.; W
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 227 KB
## Background: The first data analysis of the european organization for research and treatment of cancer (eortc) 30853 trial indicated a significantly longer time to progression and duration of survival for the maximal androgen blockade (mab) treatment arm. however, the mab treatment arm had a high